Authors
Loading...
This predictive model evaluates pathologic complete response in HER2+ breast cancer patients, suggesting enhanced patient selection for therapy.
Basho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: